Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Narcan Articles

Aoxing’s Chinese JV Hebei Aoxing gets clearance for naloxone product

25 January 2011

Mundipharma's Targin fares well vs oxycodone

1 September 2008

Mundipharma files Targin for European approval

14 July 2008

Amer Oriental buys China Aoxing stake

28 April 2008

SFDA grants Aoxing R&D license for opioid dependence drug

26 November 2007

China Aoxing sees $1.9M maiden income

15 October 2007

S-P's Suboxone approved in Scotland

19 March 2007

S-P's Suboxone now available in the UK

22 January 2007

EU approves Remicade label update for CD

16 October 2006

Suboxone viewed positively by EU regulators

7 August 2006

Opioid makers not fully responsible for abuse prevention, says FDA panel

11 February 2002

Study may result in new strategies for treating heroin addiction

3 November 2000

BOC's Revex To Be Launched Soon?

8 May 1995

ORALET APPROVAL IN USA RECOMMENDED

13 September 1993

FOCUS ON IVAX PRODUCT PIPELINE

12 October 1992

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS